The aim of this study will be to assess the effectiveness of monitored vit D supplementation in a population of preterm infants and to identify whether the proper vit D supplementation in preterm infants can reduce the incidence of neonatal sepsis and incidence of metabolic bone disease.
preterm infants with a gestational age of 24+0/7 to 32+6/7 born at our clinic
preterm infants with a gestational age of 24+0/7 to 32+6/7 outborn and admitted to our intensive care unit within 48h after delivery
written informed consent form caregivers for the mother and the child to participate in the study
infants born at >32 weeks of gestation
infants with major congenital abnormalities or other severe congenital malformations
infants with genetic disorders (diagnosed before and after birth) deemed incompatible with survival
infants with diagnosed cholestasis
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Lead sponsor
Medical University of Warsaw
Collaborator